Release date: 2018-03-28

Medtronic's CGM (Dynamic Blood Glucose Monitor) Guardian Connect has received FDA approval for patients with multiple daily insulin injections (MDI). Medtronic's pump user closed loop system was licensed in 2016.

“Although the advantages and advances of technology have been proven, only a few insulin-infected diabetics now use the Dynamic Blood Glucose Monitor (CGM),” said Dr. Timothy Bailey, Clinical Associate Professor of the University of California, San Diego, at the AMCR Institute. Medtronic said in a statement. “The combination of new sensors and intelligent algorithms helps predict and interpret glucose changes, especially for hypoglycemic conditions, which makes insulin injections safer and easier to interpret.” More use of smart CGM systems Patients will be allowed to achieve better time zone blood glucose monitoring and further reduce the risk of hypoglycemia.

The Guardian Connect system consists of a Guardian sensor 3 and an additional transmitter. The transmitter can send a continuous blood glucose signal to the application loaded on the user's smartphone. The application can alert patients to hyperglycemia or hypoglycemia 60 minutes in advance.

The application includes the IBM Watson-driven Sugar.IQ recommendation system, which was launched and demonstrated in 2016. This system gives users personalized advice on diabetes and exercise based on blood glucose reading and self-reported data.

One question that diabetes patients are trying to answer is “How much insulin do I need now?” Huzefa Neemuchwala, senior director of data and informatics innovation at Medtronic, points out. "This is a question that the FDA won't let us answer directly because it depends on a lot of things. Did you sleep well last night? Are you sick? Are you nervous this morning? You know. What is your blood sugar? You What is the historical blood sugar level? There are many factors that affect how much insulin you take now. But if you introduce more and more of these data streams, you can get a lot of insulin through a similar situation in the past. It is your reaction. 'This is the answer that you can get the closest to the real answer."

“The FDA's approval of the Guardian Connect system fills a key gap in the current treatment of diabetes – how to predict dangerous blood sugar changes so that they can be avoided,” Annette Brüls, president of Medtronic's diabetes services and solutions, said in a statement. Say. “By predicting alerts and blood glucose IQ assistants, the Guardian Connect system enables people to proactively control their diabetes so they can focus on life instead of continuing to worry about their blood sugar levels.”

Reference materials:

[1]FDA clears Medtronic's smartphone-connected CGM for MDI users

Source: Health New Vision

Skin Care Powder

Skin Care Powder,Honeysuckle Extract,Honey Powder,Eriobotrya Japonica Leaf Extract

Fufeng Sinuote Biotechnology Co.,Ltd. , https://www.sntbiology.com